scispace - formally typeset
N

Nathan L. Absalom

Researcher at University of Sydney

Publications -  40
Citations -  1169

Nathan L. Absalom is an academic researcher from University of Sydney. The author has contributed to research in topics: Receptor & GABAA receptor. The author has an hindex of 17, co-authored 38 publications receiving 958 citations. Previous affiliations of Nathan L. Absalom include Garvan Institute of Medical Research & University of New South Wales.

Papers
More filters
Journal ArticleDOI

Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

TL;DR: Pharmacological analysis indicates that RgIA and Vc1.1 are selective antagonists of alpha9alpha10 nAChRs, a subset of peptides used offensively by carnivorous marine snails known as Conus that appear to accelerate the recovery of function after nerve injury.
Journal ArticleDOI

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.

TL;DR: The present study aimed to address the nature of the interaction between CBD and clobazam to address speculation that the anticonvulsant efficacy of CBD may simply reflect CBD augmenting clobzam exposure.
Journal ArticleDOI

α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB).

TL;DR: The authors' data link specific GHB forebrain binding sites with α4-containing GABAA receptors and postulate a role for extrasynaptic α4δ-containing GHB receptors in GHB pharmacology and physiology to aid in elucidating the molecular mechanisms behind the proposed function of GHB as a neurotransmitter and its unique therapeutic effects in narcolepsy and alcoholism.
Journal ArticleDOI

Role of charged residues in coupling ligand binding and channel activation in the extracellular domain of the glycine receptor.

TL;DR: Results indicate that loops 2 and 7 in the extracellular domain play an important role in the mechanism of activation of the glycine receptor although not by a direct electrostatic mechanism.
Journal ArticleDOI

Oxytocin prevents ethanol actions at δ subunit-containing GABAA receptors and attenuates ethanol-induced motor impairment in rats.

TL;DR: This study provides the first evidence of oxytocin having a direct, non-OTR–mediated effect on GABA–ethanol interactions, and shows a previously unidentified mechanism through which some of these effects may occur.